medigraphic.com
ISSN 1561-3003 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cubana Hig Epidemiol 2013; 51 (2)

Prognostic value of the first fasting glycemia on hospital admission in people with acute myocardial infarction

Valdés JI, Licea PME, Fernández MI, Armas RNB

Language: Spanish
References: 38
Page: 140-154
PDF size: 160.75 Kb.


ABSTRACT

Background: it is described that the first fasting glycemia in people hospitalized with acute myocardial infarction is associated to a bad prognosis.
Objective: to determine the possible influence of hyperglycemia, particularly in the first fasting glycemia, for the prognosis of acute myocardial infarction.
Methods: a transversal and descriptive study was conducted in which 157 clinical histories of patients admitted to the Coronary Care unit of the Institute of Cardiology and Cardiovascular Service in Havana Province, who were diagnosed with acute myocardial infarction, were reviewed (January 2006-December 2007). They were divided into three groups: 1) without antecedents of diabetes mellitus, with hyperglycemia on admission; 2) with previous diagnosis of diabetes mellitus on admission; 3) non-diabetics, without hyperglycemia on admission. The variables studied were: age, sex, smoking habit, alcohol intake, levels of first fasting glycemia, average values of blood glucose during hospitalization, insulin treatment (conventional or intensive), complications of acute myocardial infarction, evolution (mortal or non-mortal) and hospital stay. The values of glycemia and its treatment were correlated with cardiovascular complications, mortality and hospital stay.
Results: groups 1 and 2 presented higher percentages of complications of acute myocardial infarction as well as a greater mortality in higher numbers of intrahospital blood glucose. There was a non significant tendency of first fasting glycemia with this prognosis.
Conclusions: the bad or regular intra-hospital metabolic control is associated to a bad prognosis and a greater hospital stay. There was no significant relation between first fasting glycemia and mortality after acute myocardial infarction.


REFERENCES

  1. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis. 1996;7:116-23.

  2. Lopaschuk GD. Metabolismo y función miocárdica en la diabetes. Heart Metab. 2001;11:3-7.

  3. Kannel WB, McGee DL. Diabetes and cardiovascular risk factor: the Framingham study. Circulation. 1979;59:8-13.

  4. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochem Biophys Acta .1994;1213:163-276.

  5. Méndez M, Dubois C, Sinnaeve P, Piessens J, Desmet W. La hiperglucemia de ingreso se asocia a mayor mortalidad en personas con IAM y supradesnivel del ST sometidos a angioplastía primaria. Rev Chilena Cardiol. 2006;25:253-8.

  6. Weston C, Walker L, Birkhead J. Early impact of insulin treatment on mortality for hyperglycemic patients without known diabetes who present with an acute coronary syndrome. Heart. 2007;93:1542-6.

  7. Ceriello A. Cardiovascular effects of acute hyperglycaemia: path physiological underpinnings. Diab Vasc Dis Res. 2008;5:260-8.

  8. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.

  9. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, Timmis AD. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart. 2003;89:512-6.

  10. Ishihara M, Kojima S, Sakamoto T, Asasda Y, Tej C, Kimura K, et al. Acute hyperglycemia is associated with adverse outcomes after acute myocardial infarction in the coronary intervention era. Am Heart J. 2005;150:814-20.

  11. López MA, López C, Gómez MA. Hiperglucemia durante la fase aguda del infarto del miocardio y su efecto en la función de expulsión del ventrículo izquierdo. Med Intern Mex. 2007;23:4493-7.

  12. Singh PP, Lazo RM, Nesto RW. Do nondiabetic patients with acute coronary syndromes and hyperglycaemia benefit from insulin therapy? Nature Clin Pract Cardiovasc. Med 2008;5:312-3.

  13. Webster KA. Stress hyperglycemic and enhance sensivity to myocardial infarction. Curr Hypertens. 2008;10:1522-34.

  14. Vivas D, García JC, González JJ, Nuñez I, del Prado N, Fernández A, Macaya C. Valor pronóstico de la primera glucemia en ayunas en comparación con la glucemia al ingreso en pacientes con síndrome coronario agudo. Rev Esp Cardiol. 2008;61:458-64.

  15. Otten R, Kline-Rogers E, Meier DJ, Dumasia R, Fang J, May N, et al. Impact of pre-diabetic state on clinical outcomes in patient with acute coronary syndrome. Heart. 2005; 91:1466-8.

  16. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction: a six-year follow-up study. JAMA. 1975;233:807-9.

  17. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA. 1981;246:1690-3.

  18. Licea ME. Autocontrol de la diabetes mellitus. En: Licea ME ed. Tratamiento de la diabetes mellitus. Brasilia: Ed. Ideal; 1995. p.77-85.

  19. The Expert Committee on the Diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7.

  20. Roca R. Cardiopatia isquémica. En: Roca R, editor. Temas de Medicina Interna. Vol 1. La Habana: Ed. Ciencias Médicas; 2002. p. 392-418.

  21. The Seventh Report of the Joint National Committee on Prevention, Detection and treatment of high blood pressure. Hypertension. 2003; 42: 1206-25.

  22. Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Dubiel JS, Dudek D. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol. 2010;11:715-21.

  23. Zamora A, Marrugat J. Pronóstico de los pacientes diabéticos con cardiopatia isquémica. Rev Esp Cardiol. 2002;55:751-62.

  24. Cheung NW, Wong VW, McLean M. The hyperglycemia: intensive insulin infusion in infarction (HI-5) Study. Diabetes Care. 2006;29:765-70.

  25. Malmberg K. Prospective randomized Study of intensive insulin treatment on long term survival alter acute Myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314:1512-5.

  26. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:65061.

  27. Clark RS, English M, McNeill GP, Newton RW. Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction. Br Med J. 1985;291:3035.

  28. Fernández-Fúnez A, Cabrera R, Hernández A. Enfermedad del músculo cardíaco en la diabetes mellitus. Med Clin (Barc). 2000;115:27-35.

  29. Licea ME, Batista ME, Prohías JA, Seuc A. Factores asociados a disfunción ventricular izquierda subclínica en diabéticos tipo I. Av Diabetol. 1996;12:136-46.

  30. Singh O, Licea ME, Martínez R, Díaz A. Disfunción ventricular subclínica en diabéticos tipo 1 con más de 10 años de evolución de la diabetes. Rev Cubana Endocrinol. 2001;12:05-114.

  31. Licea ME, Singh O, Martínez R, Díaz A. Disfunción ventricular subclínica en diabéticos tipo 1 con menos de 10 años de evolución de la diabetes. Rev Cubana Endocrinol. 2001;12:35-44.

  32. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. On behalf of the DIGAMI Study Group: A randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: effects on mortality it 1 year. J Am Coll Cardiol. 1995;26:5765.

  33. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:135967.

  34. Iliceto S. Enfermedad arterial coronaria y diabetes. Heart Metab. 2001;11:1-2.

  35. Sala J, Marrugat J, Masia R, Porta-Serra M, the REGICOR Investigators. Improvement in survival after myocardial infarction between 1978-1985 in the REGICOR study. Eur Heart J. 1995;16:779-84.

  36. Fergus TS, Fazel R, Fang J, Chetcuti S, Smith DE, Kline-Rogers E, et al. Presentation, management and outcomes of diabetic patients compared to nondiabetic patients admitted for acute coronary syndromes. Heart. 2004;90:1051-2.

  37. Capes S, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.

  38. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation. 2005;111:754-60.




2020     |     www.medigraphic.com